For instance, it has been reported that high serum IL-6 levels are associated with disease activity in rheumatoid arthritis (RA) and systemic lupus erythematosus, and with more severe clinical manifestations in scleroderma, indicating that IL-6 levels could serve as a biomarker for disease duration [51–55]. Here, IL6 is linked to systemic lupus erythematosus.